191 related articles for article (PubMed ID: 24131981)
1. Adeno-associated virus serotypes 9 and rh10 mediate strong neuronal transduction of the dog brain.
Swain GP; Prociuk M; Bagel JH; O'Donnell P; Berger K; Drobatz K; Gurda BL; Haskins ME; Sands MS; Vite CH
Gene Ther; 2014 Jan; 21(1):28-36. PubMed ID: 24131981
[TBL] [Abstract][Full Text] [Related]
2. Transduction of the central nervous system after intracerebroventricular injection of adeno-associated viral vectors in neonatal and juvenile mice.
Gholizadeh S; Tharmalingam S; Macaldaz ME; Hampson DR
Hum Gene Ther Methods; 2013 Aug; 24(4):205-13. PubMed ID: 23808551
[TBL] [Abstract][Full Text] [Related]
3. Adeno-associated virus (AAV) serotypes 2, 4 and 5 display similar transduction profiles and penetrate solid tumor tissue in models of human glioma.
Thorsen F; Afione S; Huszthy PC; Tysnes BB; Svendsen A; Bjerkvig R; Kotin RM; Lønning PE; Hoover F
J Gene Med; 2006 Sep; 8(9):1131-40. PubMed ID: 16810631
[TBL] [Abstract][Full Text] [Related]
4. Adeno-associated viral serotypes differentially transduce inhibitory neurons within the rat amygdala.
de Solis CA; Hosek MP; Holehonnur R; Ho A; Banerjee A; Luong JA; Jones LE; Chaturvedi D; Ploski JE
Brain Res; 2017 Oct; 1672():148-162. PubMed ID: 28764932
[TBL] [Abstract][Full Text] [Related]
5. Cellular selectivity of AAV serotypes for gene delivery in neurons and astrocytes by neonatal intracerebroventricular injection.
Hammond SL; Leek AN; Richman EH; Tjalkens RB
PLoS One; 2017; 12(12):e0188830. PubMed ID: 29244806
[TBL] [Abstract][Full Text] [Related]
6. Adeno-associated virus vectors serotyped with AAV8 capsid are more efficient than AAV-1 or -2 serotypes for widespread gene delivery to the neonatal mouse brain.
Broekman ML; Comer LA; Hyman BT; Sena-Esteves M
Neuroscience; 2006; 138(2):501-10. PubMed ID: 16414198
[TBL] [Abstract][Full Text] [Related]
7. Adeno-associated virus type 6 is retrogradely transported in the non-human primate brain.
San Sebastian W; Samaranch L; Heller G; Kells AP; Bringas J; Pivirotto P; Forsayeth J; Bankiewicz KS
Gene Ther; 2013 Dec; 20(12):1178-83. PubMed ID: 24067867
[TBL] [Abstract][Full Text] [Related]
8. Transduction characteristics of adeno-associated virus vectors expressing cap serotypes 7, 8, 9, and Rh10 in the mouse brain.
Cearley CN; Wolfe JH
Mol Ther; 2006 Mar; 13(3):528-37. PubMed ID: 16413228
[TBL] [Abstract][Full Text] [Related]
9. Adeno-associated virus vector-mediated transduction in the cat brain.
Vite CH; Passini MA; Haskins ME; Wolfe JH
Gene Ther; 2003 Oct; 10(22):1874-81. PubMed ID: 14502216
[TBL] [Abstract][Full Text] [Related]
10. Circulating anti-wild-type adeno-associated virus type 2 (AAV2) antibodies inhibit recombinant AAV2 (rAAV2)-mediated, but not rAAV5-mediated, gene transfer in the brain.
Peden CS; Burger C; Muzyczka N; Mandel RJ
J Virol; 2004 Jun; 78(12):6344-59. PubMed ID: 15163728
[TBL] [Abstract][Full Text] [Related]
11. Axonal transport of adeno-associated viral vectors is serotype-dependent.
Salegio EA; Samaranch L; Kells AP; Mittermeyer G; San Sebastian W; Zhou S; Beyer J; Forsayeth J; Bankiewicz KS
Gene Ther; 2013 Mar; 20(3):348-52. PubMed ID: 22418061
[TBL] [Abstract][Full Text] [Related]
12. Tropism and toxicity of adeno-associated viral vector serotypes 1, 2, 5, 6, 7, 8, and 9 in rat neurons and glia in vitro.
Howard DB; Powers K; Wang Y; Harvey BK
Virology; 2008 Mar; 372(1):24-34. PubMed ID: 18035387
[TBL] [Abstract][Full Text] [Related]
13. Gene delivery to the vasculature mediated by low-titre adeno-associated virus serotypes 1 and 5.
Sen S; Conroy S; Hynes SO; McMahon J; O'Doherty A; Bartlett JS; Akhtar Y; Adegbola T; Connolly CE; Sultan S; Barry F; Katusic ZS; O'Brien T
J Gene Med; 2008 Feb; 10(2):143-51. PubMed ID: 18067196
[TBL] [Abstract][Full Text] [Related]
14. Higher Transduction Efficiency of AAV5 to Neural Stem Cells and Immature Neurons in Gerbil Dentate Gyrus Compared to AAV2 and rh10.
Sehara Y; Hayashi Y; Ohba K; Uchibori R; Urabe M; Inutsuka A; Shimazaki K; Kawai K; Mizukami H
Hum Gene Ther; 2022 Jan; 33(1-2):76-85. PubMed ID: 34348481
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the efficacy of five adeno-associated virus vectors for transducing dorsal raphé nucleus cells in the mouse.
Vincent M; Gao G; Jacobson L
J Neurosci Methods; 2014 Sep; 235():189-92. PubMed ID: 25046366
[TBL] [Abstract][Full Text] [Related]
16. Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2.
Rutledge EA; Halbert CL; Russell DW
J Virol; 1998 Jan; 72(1):309-19. PubMed ID: 9420229
[TBL] [Abstract][Full Text] [Related]
17. Pseudotyped adeno-associated viral vectors for gene transfer in dermal fibroblasts: implications for wound-healing applications.
Balaji S; King A; Dhamija Y; Le LD; Shaaban AF; Crombleholme TM; Keswani SG
J Surg Res; 2013 Sep; 184(1):691-8. PubMed ID: 23590866
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the transduction efficiency of tyrosine-mutant adeno-associated virus serotype vectors in kidney.
Qi YF; Li QH; Shenoy V; Zingler M; Jun JY; Verma A; Katovich MJ; Raizada MK
Clin Exp Pharmacol Physiol; 2013 Jan; 40(1):53-5. PubMed ID: 23216315
[TBL] [Abstract][Full Text] [Related]
19. Pre-existing immunity to adeno-associated virus (AAV)2 limits transgene expression following intracerebral AAV2-based gene delivery in a 6-hydroxydopamine model of Parkinson's disease.
Janelidze S; Nordström U; Kügler S; Brundin P
J Gene Med; 2014; 16(9-10):300-8. PubMed ID: 25303717
[TBL] [Abstract][Full Text] [Related]
20. Intraventricular brain injection of adeno-associated virus type 1 (AAV1) in neonatal mice results in complementary patterns of neuronal transduction to AAV2 and total long-term correction of storage lesions in the brains of beta-glucuronidase-deficient mice.
Passini MA; Watson DJ; Vite CH; Landsburg DJ; Feigenbaum AL; Wolfe JH
J Virol; 2003 Jun; 77(12):7034-40. PubMed ID: 12768022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
